Pregnenolone as an adjunct to risperidone for treatment of women with schizophrenia: A randomized double-blind placebo-controlled clinical trial-Reference-Cited by-同舟云学术

Pregnenolone as an adjunct to risperidone for treatment of women with schizophrenia: A randomized double-blind placebo-controlled clinical trial

Published:2017-11 Issue: Volume:94 Page:70-77
ISSN:0022-3956
Container-title:Journal of Psychiatric Research
language:en
Short-container-title:Journal of Psychiatric Research

Author:

Kashani Ladan,Shams Nazila,Moazen-Zadeh Ehsan^ORCID,Karkhaneh-Yousefi Mohammad-Ali,Sadighi Gita,Khodaie-Ardakani Mohammad-Reza,Rezaei Farzin,Rahiminejad Fatemeh,Akhondzadeh Shahin

Funder

Tehran University of Medical Sciences (TUMS)

Publisher

Elsevier BV

Subject

Biological Psychiatry,Psychiatry and Mental health

Reference45 articles.

1. Effect of ritanserin, a 5HT2A/2C antagonist, on negative symptoms of schizophrenia: a double-blind randomized placebo-controlled study;Akhondzadeh;Prog. Neuropsychopharmacol. Biol. Psychiatry,2008

2. More ACTIONS needed to reach a consensus on adjunctive antidepressant therapy for negative symptoms of schizophrenia;Akhondzadeh;Evid. Based Ment. Health,2017

3. Sex differences in the risk of schizophrenia: evidence from meta-analysis;Aleman;Arch. Gen. Psychiatry,2003

4. Gender differences in electroconvulsive therapy: a retrospective chart review;Bloch;J. Affect. Disord.,2005

5. Prevalence of negative symptoms in outpatients with schizophrenia spectrum disorders treated with antipsychotics in routine clinical practice: findings from the CLAMORS study;Bobes;J. Clin. Psychiatry,2009

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multimodal electrophysiological analyses reveal that reduced synaptic excitatory neurotransmission underlies seizures in a model of NMDAR antibody-mediated encephalitis;Communications Biology;2021-09-20

2. In vitro characterisation and neurosteroid treatment of an N-Methyl-D-Aspartate receptor antibody-mediated seizure model;2020-12-22

3. Efficacy and safety of anti-inflammatory agents in treatment of psychotic disorders – A comprehensive systematic review and meta-analysis;Brain, Behavior, and Immunity;2020-11

4. Vortioxetine as adjunctive therapy to risperidone for treatment of patients with chronic schizophrenia: A randomised, double-blind, placebo-controlled clinical trial;Journal of Psychopharmacology;2020-03-02

5. Role of the Endocannabinoid System in the Pathophysiology of Schizophrenia: Implications for Pharmacological Intervention;CNS Drugs;2018-07